Role of complement and perspectives for intervention in transplantation

Area of Science:

• Immunology
• Transplantation Biology
• Innate Immunity

Background:

• The complement cascade is a key component of the innate immune response.
• Complement activation is implicated in various stages of organ transplant rejection, including hyperacute, acute antibody-mediated, and cell-mediated rejection.
• Complement proteins contribute to ischemia-reperfusion injury and can trigger adaptive immune responses.

Purpose of the Study:

• To review recent findings on the role of complement in organ transplantation.
• To discuss complement's involvement in graft ischemia-reperfusion injury, antibody-mediated rejection, and cell-mediated rejection.
• To examine current complement intervention therapies and explore future therapeutic strategies.

Main Methods:

• Literature review of recent findings on complement in transplantation.
• Analysis of complement's role in different types of transplant rejection and injury.
• Discussion of clinical complement intervention therapies and potential new strategies.

Main Results:

• Complement activation generates chemoattractants (C3a, C5a) and the membrane attack complex, mediating tissue injury.
• Evidence supports complement's critical role in hyperacute and acute antibody-mediated rejection.
• Increasing evidence suggests complement involvement in ischemia-reperfusion injury and cell-mediated rejection.

Conclusions:

• Complement plays a multifaceted role in the pathogenesis of organ transplant rejection and injury.
• Understanding complement's mechanisms is crucial for developing effective transplant therapies.
• Complement intervention therapies hold significant potential for improving clinical transplantation outcomes.